Novak Djokovic has purchased 80% of Danish biotech firm QuantBioRes, aiming to develop a medical treatment against COVID-19, the company's chief executive told Reuters reut.rs/3rzUZkq
QuantBioRes CEO Ivan Loncarevic, who describes himself as an entrepreneur, says the investment was made in June 2020 but declined to reveal the amount reut.rs/3FDhMAR
QuantBioRes has around 11 researchers working in Denmark, Australia and Slovenia, according to Loncarevic, who stresses they were working on a treatment, not a vaccine
The company is developing a peptide, which inhibits the coronavirus from infecting the human cell and expects to launch clinical trials in Britain this summer, Loncarevic added
Djokovic has stoked global debate about the rights of people who opt not to get vaccinated after he was deported from Australia on Sunday night, ruling him out of the #AusOpen reut.rs/3FDhMAR
Share this Scrolly Tale with your friends.
A Scrolly Tale is a new way to read Twitter threads with a more visually immersive experience.
Discover more beautiful Scrolly Tales like this.